BRCC3 and myelodysplastic syndrome: While recurrent mutations in BRCC3 have been recently described in myelodysplastic syndromes (MDS) [28], only one BRCC3 mutation has been identified in a patient with complex karyotype in the TCGA AML cohort of 200 cases [29].